Tumor necrosis factor-alpha (TNFα) antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and ankylosing spondylitis [1, 2]. Here, TNF is linked to psoriatic arthritis.